Zentiva Competitors and Similar CompaniesClear all
Grunenthal's competitors and similar companies include Biocodex, Swedish Orphan Biovitrum and Ipsen.
 Swedish Orphan Biovitrum Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care. | ||||
Founding Date | Founding Date 1946 | Founding Date 1953 | Founding Date 2010 | Founding Date 1929 |
Type | Type Private | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Gentilly, FR HQ Anderlecht, BE Espoo, FI Ciudad De México, MX Nouasseur, MA Warszawa, PL Lisboa, PT see more | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | ||
Employees | Employees 4,590 | Employees 1,5741% increase | Employees 1,895 | Employees 5,358 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 11.1 b | Valuation ($) 10.2 b |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €310m (FY, 2018) | Revenue (est.) kr28.2b (FY, 2025) | Revenue (est.) €3.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods kr6.2b (FY, 2025) | Cost of goods €659.1m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit kr22b (FY, 2025) | Gross profit €3.3b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income kr476m (FY, 2025) | Net income €445.1m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Biocodex
HQ
Gentilly, FR
Employees
1,574↑ 1% increase
Biocodex is a pharmaceutical company that specializes in the development of drugs.
View companySwedish Orphan Biovitrum
HQ
Solna, SE
Employees
1,895
Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care.
View company